tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nigel Dally, 61 are a SELL (12.79%), 256 are a HOLD (53.67%), 160 are a BUY (33.54%).
Analyst Nigel Dally, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 79.27% that have a potential upside of 40.11% achieved within 345 days.
Nigel Dally’s has documented 918 price targets and ratings displayed on 24 stocks. The coverage is on Financial Services, Healthcare, Communication Services, Basic Materials sectors.
Most recent stock forecast was given on MET, MetLife at 06-Jul-2026.
Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS ).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 11/13/2023. The price target of $10 was fulfilled within 106 days with a profit of $7.89 (373.93%) receiving and performance score of 35.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 25-Apr-2018
$110
$-15.6 (-12.42%)
$100
6 days ago
(22-Jul-2026)
8/9 (88.89%)
$-13.58 (-10.99%)
213
Hold Since 27-Aug-2015
$120
$-5.6 (-4.46%)
$115
15 days ago
(13-Jul-2026)
10/11 (90.91%)
$-3.3 (-2.68%)
106
Sell Since 01-Feb-2024
$115
$-10.6 (-8.44%)
$111
15 days ago
(13-Jul-2026)
13/15 (86.67%)
$-8.3 (-6.73%)
112
Hold Since 28-Jun-2024
$108
$-17.6 (-14.01%)
$84
18 days ago
(10-Jul-2026)
11/14 (78.57%)
$-13.91 (-11.41%)
90
Hold Since 12-Aug-2024
$120
$-5.6 (-4.46%)
$111
19 days ago
(09-Jul-2026)
2/5 (40%)
$-1.99 (-1.63%)
50
Which stock is Nigel Dally is most bullish on?
Which stock is Nigel Dally is most reserved on?
What Year was the first public recommendation made by Nigel Dally?
